30 related articles for article (PubMed ID: 16596212)
1. Identification of plasma protein markers common to patients with malignant tumour and Abnormal Savda in Uighur medicine: a prospective clinical study.
Upur H; Chen Y; Kamilijiang M; Deng W; Sulaiman X; Aizezi R; Wu X; Tulake W; Abudula A
BMC Complement Altern Med; 2015 Feb; 15():9. PubMed ID: 25652121
[TBL] [Abstract][Full Text] [Related]
2. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
[TBL] [Abstract][Full Text] [Related]
3. [Serum diagnosis of head and neck squamous cell carcinoma using surface-enhanced desorption ionization mass spectrometry and artificial neural network analyses].
Cao SM; Guo X; Chen FJ; Yang AK; Chen WK; Li NW
Ai Zheng; 2007 Jul; 26(7):767-70. PubMed ID: 17626756
[TBL] [Abstract][Full Text] [Related]
4. Elevated levels of the acute-phase serum amyloid are associated with heightened lung cancer risk.
Cremona M; Calabrò E; Randi G; De Bortoli M; Mondellini P; Verri C; Sozzi G; Pierotti MA; La Vecchia C; Pastorino U; Bongarzone I
Cancer; 2010 Mar; 116(5):1326-35. PubMed ID: 20087959
[TBL] [Abstract][Full Text] [Related]
5. Identification of a plasma proteomic signature to distinguish pediatric osteosarcoma from benign osteochondroma.
Li Y; Dang TA; Shen J; Perlaky L; Hicks J; Murray J; Meyer W; Chintagumpala M; Lau CC; Man TK
Proteomics; 2006 Jun; 6(11):3426-35. PubMed ID: 16673437
[TBL] [Abstract][Full Text] [Related]
6. Plasma proteomic profiling: search for lung cancer diagnostic and early detection markers.
Ali IU; Xiao Z; Malone W; Smith M; Conrads TP; Veenstra TD; Greenwald P; Luke BT; McLarty JW
Oncol Rep; 2006 May; 15(5):1367-72. PubMed ID: 16596212
[TBL] [Abstract][Full Text] [Related]
7. Proteomics in the diagnosis of hepatocellular carcinoma: focus on high risk hepatitis B and C patients.
El-Aneed A; Banoub J
Anticancer Res; 2006; 26(5A):3293-300. PubMed ID: 17094443
[TBL] [Abstract][Full Text] [Related]
8. Clinical proteomics and mass spectrometry profiling for cancer detection.
Solassol J; Jacot W; Lhermitte L; Boulle N; Maudelonde T; Mangé A
Expert Rev Proteomics; 2006 Jun; 3(3):311-20. PubMed ID: 16771703
[TBL] [Abstract][Full Text] [Related]
9. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
10. [Proteomics and breast cancer].
Mathelin C; Tomasetto C; Cromer A; Rio MC
Gynecol Obstet Fertil; 2006 Dec; 34(12):1161-9. PubMed ID: 17123853
[TBL] [Abstract][Full Text] [Related]
11. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
Bharti A; Ma PC; Salgia R
Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]